Skip to main content

Table 5 Baseline characteristics and treatment responses of 360 children enrolled in the parasitaemia elimination half-life study

From: Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria

Variables

2009–2010

(n = 254)

2012–2015

(n = 106)

All

(n = 360)

P value

Baseline characteristics

 Male∶Female

141∶113

53∶53

194∶166

0.4

 Age (month)

  Mean

7.3

7.5

7.4

0.64

  95% CI

6.9–7.7

6.8–8.1

7.0–7.7

 

  Number 5 years (%)

54 (21.3)

22 (20.8)

76 (21.1)

1.0

 Temperature (°C)

  Mean

38.4

38

38.3

0.009

  95% CI

38.2–38.5

37.8–38.3

38.2–38.4

 

 No. with

   ≥ 37.5 °C (%)*

196 (77.2)

67 (23.6)

263 (73.1)

0.01

   ≥ 40 °C (%)

26 (10.2)

4 (3.8)

30 (8.3)

0.06

 Haematocrit (%)

  Mean

32.1

32.1

32.1

0.98

  95% CI

31.6–32.6

32.1–33.0

31.7–32.6

 

  No with anaemia (%)

60 (23.6)

25 (23.6)

85 (23.6)

1.0

 Parasitaemia (μl−1)

  Geometric mean

71 393

41 404

60 811

<  0.0001

  Range

1800–1 096 636

2220–454 875

1800–1 096 636

 

   > 100 000 μl− 1 (%)

165 (65)

83 (78.3)

248 (68.9)

0.02

 Gametocytaemia (%)

7 (2.8)

2 (1.9)

9 (2.5)

1.0

Treatment responses

 Fever clearance time (day)

  Mean (95% CI)

1.1 (1.0–1.1)

1.1 (1.0–1.2)

1.1 (1.05–1.13)

0.26

 Parasite clearance time (day)

  Mean (95% CI)

1.1 (1.1–1.2)

1.4 (1.3–1.5)

1.2 (1.2–1.3)

<  0.0001

   APPD1 (%)

28 (11)

37 (34.9)

65 (18.1)

<  0.0001

   APPD2 (%)

4 (1.6)

2 (1.9)

6 (1.7)

1.0

   APPD3 (%)

3 (1.2)

0 (0)

3 (0.8)

-

 Parasite reduction ratio 1 day

  Geometric mean

3.3 × 104

3.9 × 103

1.7 × 104

<  0.0001

  Range

2.7 × 100–1.1 × 106

8.0 × 10−1–2.4 × 105

8.0 × 10−1–1.1 × 106

 

 Parasite reduction ratio 2 days

  Geometric mean

6.6 × 104

3.8 × 104

5.6 × 104

<  0.0001

  Range

1.6 × 101–1.1 × 106

1.8 × 103–3.6 × 105

1.6 × 101–1.1 × 106

 
  1. APPD1 Asexual parasite positivity 1 day post-treatment initiation, APPD2 Asexual parasite positivity 2 days post-treatment initiation, APPD3 Asexual parasite positivity 3 days post-treatment initiation, CI Confidential interval